Poly(vinylpyrrolidone-co-dimethyl maleic acid) as a novel renal targeting carrier
However, these compounded versions do not undergo the same rigorous FDA approval process as generics and branded medications, leading to concerns about safety and efficacy
It is crucial to note that whilst these early findings are encouraging, GLP-1 agonists are not currently recommended or approved for AUD treatment by NICE, the MHRA, or other regulatory bodies
Geroni C, Marchini S, Cozzi P, Galliera E, Ragg E, Colombo T, et al
GIP(1-42), K* denotes the acylated lysine, and NH 2 indicates C-terminal amidation
Similarly to IGF-I, vascular endothelial growth factor (VEGF) affects the survival and proliferation of endothelial cells, neurons and astrocytes in the brain, suggesting a potential therapeutic application in PD [32]